abstract |
The object of the invention relates to gastro-resistant tablets containing rifaximin, obtained by means of gastro-resistant microgranules characterized in that they inhibit the release of rifaximin at pH values between 1.5 and 4.0, and allow their release at pH values between 5.0 and 7.5, the process of obtaining it and its use in the treatment and prevention of diseases directly or indirectly derived from inflammatory bowel diseases. |